# EndoArt to launch hip endoprosthesis plant in St. Petersburg

EndoArt, a subsidiary of BSS pharmaceutical holding, is launching a plant in St. Petersburg for cemented and cementless hip endoprostheses. The project required 1 billion rubles in investment, with capacity for up to 35,000 units annually. The plant is set to launch in August 2024.

- Type: New facility
- Announced: 2024-07-31
- Where: St. Petersburg, Russia, Russia
- Value: $11.0M (1.00B RUB)
- Starts operating: Aug 2024
- Status: under construction
- Capacity: 35,000 units annually
- Products: hip endoprostheses
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [EndoArt](https://endata.com/companies/78905.md)
- [BSS](https://endata.com/companies/78906.md) (investor)

## Sources

- [gxpnews.net](https://gxpnews.net/en/2024/07/1-billion-rubles-invested-in-new-endoprosthesis-production-facility-in-st-petersburg/), 2024-07-31: "The EndoArt company, a subsidiary of the BSS pharmaceutical holding, is gearing up to launch a plant for the production of cemented and cementless hip endoprostheses."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.